SID 2026Abstract 0606
Contribution of STAT-3 gain-of-function mutation to cutaneous sclerosis ameliorated by JAK inhibitor therapy
Buechler C, Pearson D
SID Annual Meeting 2026Genetics & epigeneticsChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: JAK inhibitors & other targeted pills
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.637 · Not in PubMed: details from Crossref